Study of mRNA expression of vascular endothelial growth factor -(A, C, D) genes and its effect on prognosis of breast cancer

Chinese Journal of Pathology

Volumn 35, Issue 8, 2006, Pages 473-477

  Zhang, Gui Hong ^a   Zeng, Yu ^a   Yang, Wen Tao ^a   Shi, Da Ren ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast neoplasms; Endothelial growth factors; Prognosis; Reverse transcriptase polymerase chain reaction; RNA, messenger

Indexed keywords

MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ARTICLE; BREAST CARCINOMA; BREAST LESION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 33750079295     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature, 2000, 407:242-248.
2. Ferrera N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med, 2003, 9:669-676.
3. Joukov V, Pajuaola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, as a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 1996, 15:290-298.
4. Marconcini L, Marchio S, Morbidelli L, et al. c-fos-indueed growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A, 1999, 96:9671-9676.
5. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A, 1995, 92:3566-3570.
6. Hamada K, Dike Y, Takakura N, et al. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood, 2000, 96:3793-3800.
7. Nathanson SD. Insight into the mechanisms of lymph node metastasis. Cancer, 2003, 98:413-423.
8. He Y, Karpanen T, Alitalo K, et al. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta, 2004, 1654:3-12.
9. Yang W, Klos K, Yang Y, et al. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C and D in human breast carcinoma. Cancer, 2002, 94:2855-2861.
10. Koyama Y, Kaneko K, Akazawa K, et al. Vascular endothelial growth factor C and vascular endothelial growth factor D messenger RNA expression in breast cancer association with lymph node metastasis. Clin Breast Cancer, 2003, 4:354-360.
11. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res, 2001, 61:1786-1790.
12. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med, 2001, 7:186-191.
13. Niki T, Iba S, Tokunou M, et al. Expression of vascular endothelial growth factor A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res, 2000, 6:2431-2439.